Examining vein wall thickness and inflammation in Behçet disease patients
Official title: Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
Run by Sohag University · NCT06721234 · Data updated 2026-11-12
This study looks at the thickness of vein walls and signs of inflammation in adults with Behçet disease to see how these factors relate to the disease's activity and symptoms.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years to 80 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | December 2, 2024 |
| Main results expected | April 30, 2025 |
| Study ends | July 30, 2025 |
| Registry record updated | December 10, 2024 |
| Trial ID | NCT06721234 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old who have been diagnosed with Behçet disease according to established criteria.
✕Probably not a fit
Patients with other rheumatological or vascular diseases, or those with significant comorbidities such as hypertension or diabetes, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the thickness of the femoral vein wall and inflammatory markers in patients diagnosed with Behçet disease. It aims to assess the relationship between these factors and the activity of the disease, as well as associated clinical manifestations. The study includes adult patients who meet the International Criteria for Behçet's Disease and are able to provide informed consent. By analyzing these parameters, the study seeks to enhance understanding of the disease's impact on vascular health.
Why it matters
Potential benefit: If successful, this study could provide insights into the vascular complications of Behçet disease, potentially leading to improved management strategies.
How similar studies have gone: While there may be limited studies specifically focusing on vein wall thickness in Behçet disease, similar research on inflammatory markers has shown promising results in understanding disease mechanisms.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients fulfill the International Criteria for Behcet's Disease (ICBD) * Age above 18 years old * Patients cooperative and can answer questions * Patients who are able and willing to give informed consent Exclusion Criteria: * Other rheumatological and vascular diseases * Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests * Patients with hypertension , diabetes mellitus , malignant and active infectious diseases * Patients who are using aspirin and other platelet active drygs during the previous 6 months * patients who are not able and willing to give written consent
Where it's running
-
Sohag university
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Engy L Fawzy
- Email: engylouisfawzey@gmail.com
- Phone: 01282665433
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Trauma registry at Sohag University Hospital
This study tests the creation of a trauma registry in the emergency department to collect data on injured adults admitted with polytrauma at Sohag University Hospital.
-
Prevalence of Myocardial Bridging and its relation to Coronary Plaques on MDCT
This study tests how common myocardial bridging is and whether it relates to coronary plaque in patients undergoing coronary CT angiography.
-
Septoplasty: see if it changes headache symptoms
This study tests whether septoplasty can change headache severity in adults with septal deviation and headache.
-
Predicting SLE Flares with Patient Reports and Machine Learning
Aims to test a low-cost, patient-reported outcome–based machine learning tool to see if it can detect lupus flares early and support care, especially in settings with limited resources.
-
Is geographic mismatch linked to short-term major heart problems after long drug-eluting stent placement?
This study checks whether geographic mismatch can predict short-term major adverse cardiovascular events after a long drug-eluting stent is placed in the coronary arteries.
-
Biomarkers to predict no-reflow after opening the heart’s artery in STEMI patients
This study tests whether immune-inflammatory and metabolic biomarkers can predict coronary no-reflow after primary PCI in adults with STEMI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.